Sunway Medical Centre

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Myeloproliferative neoplasms2 trials
• IgA nephropathy1 trial
• Lung cancer1 trial
• Lupus (SLE)1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Janssen Research & Development, LLC3 trials
• Novartis Pharmaceuticals1 trial
• NS Pharma, Inc.1 trial
• Walden Biosciences1 trial

Running trials

• Recruiting

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Study of WAL0921 in Patients With Glomerular Kidney Diseases

  NCT06466135· Phase 2· Walden Biosciences· Source

  Contact: Michelle Skupien

• Active, not recruiting

  A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

  NCT05388669· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Active Psoriatic Arthritis

  NCT04882098· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

  NCT04603495· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy1 recruiting
• Lupus (SLE)1 recruiting

Closed trials

• Terminated

  Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis

  NCT04854096· Phase 2· NS Pharma, Inc.· Source